| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 9 3133-3140, Copyright © 1996 by American Association of Immunologists
ARTICLES |
MH Blotta, JD Marshall, RH DeKruyff and DT Umetsu
Department of Pediatrics, Stanford University, CA 94305, USA.
Although there is good evidence that the induction of IL-4 synthesis in CD4+ T lymphocytes is favored by Ag presentation by B cells and not macrophages, the precise molecular signals provided by B cells to T cells that enhance IL-4 synthesis are not clear. To examine this issue, we established an APC-independent system to activate highly purified T cells and induce cytokine synthesis, using immobilized mAbs against several T cell surface molecules, including CD3, CD28, and the CD40 ligand (CD40L). The counter-receptors for all three of these molecules are expressed on B cells, and include CD40, which is expressed primarily on B cells, but also on dendritic cells and thymic epithelium. We found that IL-4 synthesis was greatly enhanced by triggering of CD40L on the T cell surface in conjunction with ligation of CD3/TCR and CD28, whereas ligation of CD3/TCR and CD28 in the absence of CD40L triggering resulted in little or no IL-4 synthesis. CD40L costimulation greatly enhanced IL-4 synthesis both in T cells from normal nonallergic adult subjects as well as in naive T cells from cord blood. Furthermore, we demonstrated that IL-4 synthesis was optimally enhanced when the strength of the CD3/TCR signal was limiting, while IL-4 synthesis was inhibited when CD3/TCR stimulation was maximal. These studies confirm that IL-4 synthesis can be induced in normal T lymphocytes in the absence of exogenous IL-4, and demonstrate that CD40L costimulation is of fundamental importance in regulation of IL-4 production. In addition, these findings provide a mechanism by which B cells preferentially enhance IL-4 synthesis in T cells at low Ag concentrations.
This article has been cited by other articles:
|
|
 |
|
  S. J. Jenkins, G. Perona-Wright, and A. S. MacDonald Full Development of Th2 Immunity Requires Both Innate and Adaptive Sources of CD154 J. Immunol., June 15, 2008; 180(12): 8083 - 8092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Spence and E. A. Green Foxp3+ regulatory T cells promiscuously accept thymic signals critical for their development PNAS, January 22, 2008; 105(3): 973 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Arce, H. F. Nawar, G. Muehlinghaus, M. W. Russell, and T. D. Connell In Vitro Induction of Immunoglobulin A (IgA)- and IgM-Secreting Plasma Blasts by Cholera Toxin Depends on T-Cell Help and Is Mediated by CD154 Up-Regulation and Inhibition of Gamma Interferon Synthesis Infect. Immun., March 1, 2007; 75(3): 1413 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Nathan, J. E. Mold, S. C. Wood, K. Csencsits, G. Lu, E. J. Eichwald, and D. K. Bishop Requirement for Donor and Recipient CD40 Expression in Cardiac Allograft Rejection: Induction of Th1 Responses and Influence of Donor-Derived Dendritic Cells J. Immunol., June 1, 2004; 172(11): 6626 - 6633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Mikolajczak, B. Y. Ma, T. Yoshida, R. Yoshida, D. J. Kelvin, and A. Ochi The Modulation of CD40 Ligand Signaling by Transmembrane CD28 Splice Variant in Human T Cells J. Exp. Med., April 5, 2004; 199(7): 1025 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Eshima, Y. Choi, and R. A. Flavell CD154-CD40-independent up-regulation of B7-2 on splenic antigen-presenting cells and efficient T cell priming by staphylococcal enterotoxin A Int. Immunol., July 1, 2003; 15(7): 817 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Lumsden, J. A. Williams, and R. J. Hodes Differential Requirements for Expression of CD80/86 and CD40 on B Cells for T-Dependent Antibody Responses In Vivo J. Immunol., January 15, 2003; 170(2): 781 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Grassme, J. Bock, J. Kun, and E. Gulbins Clustering of CD40 Ligand Is Required to Form a Functional Contact with CD40 J. Biol. Chem., August 9, 2002; 277(33): 30289 - 30299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. MacDonald, E. A. Patton, A. C. La Flamme, M. I. Araujo, C. R. Huxtable, B. Bauman, and E. J. Pearce Impaired Th2 Development and Increased Mortality During Schistosoma mansoni Infection in the Absence of CD40/CD154 Interaction J. Immunol., May 1, 2002; 168(9): 4643 - 4649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Campbell, T. Komata, and A. Kelso CD4 Ligation Promotes the IL-4-Independent Development of IL-4-Producing Clones from Naive CD4+ T Cells J. Immunol., November 15, 2001; 167(10): 5610 - 5619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lindgren, K. Axcrona, and T. Leanderson Regulation of Transcriptional Activity of the Murine CD40 Ligand Promoter in Response to Signals Through TCR and the Costimulatory Molecules CD28 and CD2 J. Immunol., April 1, 2001; 166(7): 4578 - 4585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Gorbachev, P. S. Heeger, and R. L. Fairchild CD4+ and CD8+ T Cell Priming for Contact Hypersensitivity Occurs Independently of CD40-CD154 Interactions J. Immunol., February 15, 2001; 166(4): 2323 - 2332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Blair, J. L. Riley, D. M. Harlan, R. Abe, D. K. Tadaki, S. C. Hoffmann, L. White, T. Francomano, S. J. Perfetto, A. D. Kirk, et al. CD40 Ligand (CD154) Triggers a Short-Term CD4+ T Cell Activation Response That Results in Secretion of Immunomodulatory Cytokines and Apoptosis J. Exp. Med., February 21, 2000; 191(4): 651 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Evans, M. W. Munks, J. M. Purkerson, and D. C. Parker Resting B Lymphocytes as APC for Naive T Lymphocytes: Dependence on CD40 Ligand/CD40 J. Immunol., January 15, 2000; 164(2): 688 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Jenks and J. Miller Inhibition of IL-4 Responses After T Cell Priming in the Context of LFA-1 Costimulation Is Not Reversed by Restimulation in the Presence of CD28 Costimulation J. Immunol., January 1, 2000; 164(1): 72 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Chirmule, J. Tazelaar, and J. M. Wilson Th2-Dependent B Cell Responses in the Absence of CD40-CD40 Ligand Interactions J. Immunol., January 1, 2000; 164(1): 248 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Iwakoshi, J. P. Mordes, T. G. Markees, N. E. Phillips, A. A. Rossini, and D. L. Greiner Treatment of Allograft Recipients with Donor-Specific Transfusion and Anti-CD154 Antibody Leads to Deletion of Alloreactive CD8+ T Cells and Prolonged Graft Survival in a CTLA4-Dependent Manner J. Immunol., January 1, 2000; 164(1): 512 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Garber, L. Su, B. Ehrenfels, M. Karpusas, and Y.-M. Hsu CD154 Variants Associated with Hyper-IgM Syndrome Can Form Oligomers and Trigger CD40-mediated Signals J. Biol. Chem., November 19, 1999; 274(47): 33545 - 33550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Grammer, R. D. McFarland, J. Heaney, B. F. Darnell, and P. E. Lipsky Expression, Regulation, and Function of B Cell-Expressed CD154 in Germinal Centers J. Immunol., October 15, 1999; 163(8): 4150 - 4159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text]
|
|
|
|
|
|
D. M. Shepherd and N. I. Kerkvliet Disruption of CD154:CD40 Blocks Generation of Allograft Immunity Without Affecting APC Activation J. Immunol., September 1, 1999; 163(5): 2470 - 2477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Rogers and M. Croft Peptide Dose, Affinity, and Time of Differentiation Can Contribute to the Th1/Th2 Cytokine Balance J. Immunol., August 1, 1999; 163(3): 1205 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chabot, G. Williams, M. Hamilton, G. Sutherland, and V. W. Yong Mechanisms of IL-10 Production in Human Microglia-T Cell Interaction J. Immunol., June 1, 1999; 162(11): 6819 - 6828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Metcalfe, R. S. McIntosh, F. Marelli-Berg, G. Lombardi, R. Lechler, and A. P. Weetman Detection of CD40 on Human Thyroid Follicular Cells: Analysis of Expression and Function J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1268 - 1274. [Abstract] [Full Text]
|
|
|
|
|
|
L. A. Zuckerman, L. Pullen, and J. Miller Functional Consequences of Costimulation by ICAM-1 on IL-2 Gene Expression and T Cell Activation J. Immunol., April 1, 1998; 160(7): 3259 - 3268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Moriggl, C. Kristofic, B. Kinzel, S. Volarevic, B. Groner, and V. Brinkmann1 Activation of STAT Proteins and Cytokine Genes in Human Th1 and Th2 Cells Generated in the Absence of IL-12 and IL-4 J. Immunol., April 1, 1998; 160(7): 3385 - 3392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Macaulay, R. H. DeKruyff, and D. T. Umetsu Antigen-Primed T Cells from B Cell-Deficient JHD Mice Fail to Provide B Cell Help J. Immunol., February 15, 1998; 160(4): 1694 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M.U. Hilkens, P. Kalinski, M. de Boer, and M. L. Kapsenberg Human Dendritic Cells Require Exogenous Interleukin-12-Inducing Factors to Direct the Development of Naive T-Helper Cells Toward the Th1 Phenotype Blood, September 1, 1997; 90(5): 1920 - 1926. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
